The future of R&D innovationAlexander Gray and Mike Rea from IDEA Pharma explain why the current pharma R&D model is broken, and Share XThe future of R&D innovationhttps://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/idea-pharma-future-research-innovation/
Deep Dive: Access and CommercialisationIn this issue of Deep Dive we explore the ever present issues of market access and commercialisation, analysing Share XDeep Dive: Access and Commercialisationhttps://pharmaphorum.com/digital/pharma-access-commercialisation/
Company profile: IDEA PharmaWe are in the most competitive period ever for the pharmaceutical industry, characterised by incremental innovation and looming Share XCompany profile: IDEA Pharmahttps://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/idea-pharma-strategy/
Brexit ‘an opportunity for UK pharma’UK economy will be more dynamic, says IDEA’s Mike Rea. Share XBrexit ‘an opportunity for UK pharma’https://pharmaphorum.com/news/brexit-opportunity-uk-pharma-says-ceo/